Frontiers in Bioorganic and Medicinal Chemistry CHEM 700 / Pharm 630 / BMB 700Fall Course Directors: Cooperman and DeGrado The course explores how recent developments in our abilities to make and analyze biologically important macromolecules provide new approaches to drug development and discovery. Prerequisites: Open to all graduate students in the Chemistry, Biochemistry/Molecular Biophysics and Pharmacology departments and/or graduate groups. Other students should consult with Dr. Cooperman before enrolling. In general, a strong background in undergraduate chemistry is required, and at least one semester of biological chemistry is very desirable. 2 hourly exams 100 pts each 1 final 150 pts |
Sample Schedule from 2007
|
Lecture |
Topic |
Lecturer |
|
9/5 |
Peptide structure, amino acids and conformational properties |
DeGrado |
|
9/7 |
Peptide structure, turns and bioactive peptides |
DeGrado |
|
9/10 |
Peptide structure, statistical mechanics of helix formation |
DeGrado |
|
9/12 |
Forces stabilizing protein structure and molecular recognition |
DeGrado |
|
9/14 |
Beta-proteins |
DeGrado |
|
9/17 |
Helical proteins |
DeGrado |
|
9/19 |
Membrane proteins |
DeGrado |
|
9/21 |
Foldamers |
DeGrado |
|
9/24 |
Synthesis of polypeptides |
DeGrado |
|
9/26 |
Sequencing of polypeptides/Biosynthesis of polypeptides |
Cooperman |
|
9/28 |
Biosynthesis of polypeptides |
Cooperman |
|
10/01 |
Exam 1 |
|
|
10/03 |
DNA structure |
Cooperman |
|
10/05 |
Nucleotide modification and consequences |
Cooperman |
|
10/08 |
Biosynthesis and chemical synthesis of nucleic acids |
Cooperman |
|
10/10 |
Protein:DNA interaction |
van Duyne |
|
10/12 |
Protein:DNA interaction |
van Duyne |
|
10/17 |
Mass spectrometry and small molecules |
Blair |
|
10/19 |
Mass spectrometry and small molecules |
Blair |
|
10/22 |
Mass spectrometry and Proteomics |
Blair |
|
10/24 |
Mass spectrometry and DNA Adducts |
Blair |
|
10/26 |
Oxidative DNA Damage |
Blair |
|
10/29 |
Exam 2 |
|
|
10/31 |
Mass spectrometry and Lipids |
Blair |
|
11/02 |
Introduction to Drug Metabolism |
Blair |
|
11/05 |
Characterization of Drug Metabolism |
Blair |
|
11/07 |
RNA structure and sequencing |
Cooperman |
|
11/09 |
RNA motifs/ribozymes |
Cooperman |
|
11/12 |
Aptamers |
Cooperman |
|
11/14 |
Modifications to proteins by endogenous reactive intermediates |
Blair |
|
11/16 |
Modifications to proteins by exogenous reactive intermediates |
Blair |
|
11/19 |
Introduction to Metabolomics |
Blair |
|
11/21 |
Mechanism of Translation |
Cooperman |
|
11/26 |
Expansion of the Genetic Code |
Cooperman |
|
11/28 |
mRNA and ribosome display |
Cooperman |
|
11/30 |
Biomimetics |
Vinogradov |
|
12/03 |
Biomimetics |
Vinogradov |
|
12/05 |
Oligosaccharide structure and function |
Cooperman |
|
12/07 |
Oligosaccharide synthesis |
Cooperman |
|
|
|
![]()